MECP2 and hepatocellular carcinoma: Furthermore, the inhibition of HOXD3 expression reversed the tumor biological function‐increasing effect of MeCP2 on HCCs (Fig. 2), suggesting that MeCP2 is a key oncogene in HCC progression.